Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
1,191.540000 Euro
Request Reference:
LM 143/2024 - CP 2024/780
Request Name:
Acordo Quadro CP 2024/780 – Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas, na área da saúde
Phase:
Tendering Phase
State:
Awarded
Description:
Acordo Quadro CP 2024/780 – Medicamentos do aparelho locomotor, usados no tratamento das doenças endócrinas e hormonas, na área da saúde
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
M1055 - METFORMINA + SITAGLIPTINA [1000 MG + 50 MG; CÁP/COMP]
-
4
(
Months
)
M1056 - METFORMINA + SITAGLIPTINA [850 MG + 50 MG; CÁP/COMP]
-
4
(
Months
)
Central Purchasing Bodies
Central Purchasing Bodies
Company Name
VAT
Location
Direcção-geral de Reinserção e Serviços Prisionais
600085171
PT
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
LM - Av. Dr. Alfredo Bensaúde 1849-012 Lisboa Lisboa PORTUGAL
CPV Main Vocabulary
33690000-3 - Various medicinal products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
6/14/2024 2:36 PM
(UTC +1 hour)
National official publishing date and time (DR):
1/15/2024 12:00 AM
(UTC 0 hours)
Due datetime for receiving replies:
6/20/2024 11:59 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Anexos Editáveis.docx
Anexos Editáveis.docx
Download
LM _143_2024_OC.pdf
LM _143_2024_OC.pdf
Download
LM _143_2024_CE.pdf
LM _143_2024_CE.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Lot Title
M1055 - METFORMINA + SITAGLIPTINA [1000 MG + 50 MG; CÁP/COMP]
Base Price
893,564000
1.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
M1055
METFORMINA + SITAGLIPTINA [1000 MG + 50 MG; CÁP/COMP]
1 960,000000
NXTWY.UMT.3
Buyer Comment:
500191360 | Merck Sharp & Dohme, Lda. | CPA:2024780/193/0030 | NºAIM:5126974; 504362674 | Ciclum Farma Unipessoal, Lda. | CPA:2024780/248/0006 | NºAIM:5839550; 506037169 | Bluepharma Genéricos - Comércio de Medicamentos, S.A. | CPA:2024780/597/0230 | NºAIM:5818349; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2024780/326/0050 | NºAIM:5832522; 508107997 | Generis Farmacêutica, S.A. | CPA:2024780/263/0099 | NºAIM:5831300;
TOTAL
(The amounts shown do not include VAT)
2
Lot Title
M1056 - METFORMINA + SITAGLIPTINA [850 MG + 50 MG; CÁP/COMP]
Base Price
297,976000
2.1
Bill of Quantities
*
This price list has extra requirements. Make sure everything is completed, under each article line.
Item Code
Description
Quantity
Unit
M1056
METFORMINA + SITAGLIPTINA [850 MG + 50 MG; CÁP/COMP]
560,000000
NXTWY.UMT.3
Buyer Comment:
500191360 | Merck Sharp & Dohme, Lda. | CPA:2024780/193/0031 | NºAIM:5126941; 502248793 | Mylan, Lda. | CPA:2024780/120/0187 | NºAIM:5834957; 504362674 | Ciclum Farma Unipessoal, Lda. | CPA:2024780/248/0007 | NºAIM:5839543; 506985261 | Sandoz Farmacêutica, Lda. | CPA:2024780/326/0051 | NºAIM:5832514; 508107997 | Generis Farmacêutica, S.A. | CPA:2024780/263/0100 | NºAIM:5831276;
TOTAL
(The amounts shown do not include VAT)
Evaluation
Evaluation
Vision
Avaliação
Definir modelo de avaliação
Sim
Não
Modalidade de avaliação
Selecione…
Monofator
Método de Avaliação
Selecione…
Manual
Divulgar critérios de avaliação
Sim
Não
Critérios da Avaliação
1 - M1055 - METFORMINA + SITAGLIPTINA [1000 MG + 50 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
Definir normas de desempate?
Sim
Não
2 - M1056 - METFORMINA + SITAGLIPTINA [850 MG + 50 MG; CÁP/COMP]
Critérios da Avaliação
Descrição
Tipo de Fator
Peso (%)
1.
Preço
Preço
100%
Normas de desempate
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...